Article: Small observational study: fluvoxamine not linked to rise in fetal malformation risk.(News)

MIAMI -- The use of fluvoxamine in pregnancy is not associated with an increased risk of major fetal malformations, according to preliminary results of an ongoing observational study.

Investigators compared the pregnancy outcomes of 46 women taking the selective serotonin reuptake inhibitor to treat depression with those of 46 women taking established nonteratogenic products for the same condition. Anna Sivojelezova reported in a poster presentation at the annual meeting of the American Society for Clinical Pharmacology and Therapeutics.

Fetal survival rates, birth weight, and rates of major malformations did not differ significantly between the two ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!